Atlantic Bone Screen also work on bone diseases from tumoral origin an can evaluate the efficacy and cytotoxicity of compounds on tumoral cell lines:

  • HOS1544 (human osteosarcoma)
  • MG63 (human osteosarcoma)
  • SaOS2 (human osteosarcoma)
  • U2OS (human osteosarcoma)
  • OSRGa (rat osteosarcoma)
  • POS-1 (mouse osteosarcoma)
  • BCSCH03 (human chondrosarcoma)
  • A-673 (human Ewing sarcoma)
  • TC-71 (human Ewing sarcoma)
  • SK-ES-1 (human Ewing sarcoma)
  • RD-ES (human Ewing sarcoma)
  • CADO-ES (human Ewing sarcoma)
  • MDA-MB-231 (human mammary carcinoma)

Atlantic Bone Screen also uses these cell lines for in-vivo evaluation of compound.